ORKA Oruka Therapeutics, Inc.
Price Chart
Executive Summary
Two senior insiders at Oruka Therapeutics (CMO & SVP Finance) collectively sold ~$540K of stock on May 15-18, 2026, following derivative exercises. This represents only ~0.015% of the $3.7B market cap — a trivial dollar value relative to company size. Cluster insider SALES are not amplified by cross-filing context but the absolute materiality is negligible, making this a routine liquidity/vesting event rather than an informed signal.
Key Financial Metrics
Actionable Insight
Sales are quantitatively trivial and structurally typical of post-vesting tax-related liquidation. Flush with institutional bullishness (95% analyst buy rating) and a ~$3.7B market cap, this insider activity provides no credible trading signal. No action warranted; monitor any future large-scale C-suite selling or 10b5-1 establishment.
Key Facts
- CMO Joana Goncalves sold 4,800 shares at $61.56 for $295K on May 15
- SVP Finance Arjun Agarwal sold 4,190 shares at $58.34 for $244K on May 18
- Both sales followed derivative exercises (options/RSAs) — indicative of tax-covering liquidity sales
- Total cluster value $540K = ~0.015% of $3.7B market cap
- No C-suite CEO/CFO participation; both are second-tier executives one level below C-suite
Financial Impact
Cluster sale value of ~$540K represents 0.015% of market cap — well below 0.1% threshold for materiality
Risk Factors
- Potential further insider sales if share price continues to weaken from May highs
- No CEO or CFO participation could suggest management confidence remains intact
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ORKA-1779142117031 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
2d ago
|
Institutional Cluster
| $63.94 awaiting T+1 | awaiting T+1 | — | $69.89 (+9.31%) |
|
Jun 1, 2026
11d ago
|
8-K
| $55.23 $57.20 | ▲ +3.57% | ▲ +4.26% | $69.89 (+26.54%) |
|
May 22, 2026
21d ago
|
Insider Cluster
| $59.06 $57.99 | ▼ −1.81% | ▼ −1.82% | $69.89 (+18.34%) |
|
May 18, 2026
25d ago
|
Insider Cluster
| $57.50 $60.67 | ▲ +5.51% | ▲ +4.47% | $69.89 (+21.55%) |
|
Apr 28, 2026
6w ago
|
Press Release
| $68.10 $68.10 | · 0.00% | ▲ +1.02% | $69.89 (−2.63%) |
|
Apr 27, 2026
6w ago
|
424B5
| $73.99 $69.49 | ▲ +6.08% | ▲ +6.07% | $69.89 (+5.54%) |
|
Apr 27, 2026
6w ago
|
Press Release
| $73.99 $69.49 | ▲ +6.08% | ▲ +6.07% | $69.89 (+5.54%) |
|
Apr 27, 2026
6w ago
|
8-K
| $76.39 $73.99 | ▼ −3.14% | ▼ −2.66% | $69.89 (−8.51%) |
|
Apr 17, 2026
8w ago
|
DEFA14A
| $68.87 $69.00 | ▲ +0.19% | ▲ +0.84% | $69.89 (+1.48%) |
|
Apr 15, 2026
8w ago
|
144
| $67.07 $68.92 | ▲ +2.76% | ▲ +1.54% | $69.89 (+4.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access